Here, we are going to share Ajanta Pharma Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.
Ajanta Pharma is an Indian multinational pharmaceutical company known for the development, manufacture, and marketing of branded and generic pharmaceutical formulations.
If you are thinking for making an investment decision in Ajanta Pharma Ltd then the information shared in this article will be very beneficial for you, as we are going to share Ajanta Pharma Company Overview, Quarterly Results, Profits and Loss, Competitors, Bull and Bears cases along with Ajanta Pharma Share Price Target for 2025 to 2040.
Ajanta Pharma Company Overview
- Founded: 1973
- Founder: Mannalal Agrawal, Madhu Sudan Agrawal and Purshottam Agrawal
- Headquarters: Mumbai, Maharashtra
- No of Employees: Approx. 8,000
- Listed in: NSE and BSE
- Industry: Pharmaceuticals & Drugs
- Key Areas of Focus: Manufacturing and marketing of Medicines related to ophthalmology, dermatology, cardiology, and pain management.
- Global Presence: The company has a strong presence in more than 30 countries including United States, Asia, Africa and Latin America.
- Financial Performance: The company has shown consistent growth in revenue and profitability as well.
Ajanta Pharma Share Key Information
| Company Name | Ajanta Pharma Ltd |
| Headquarters | Mumbai, Maharashtra |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 40,262.29 Cr. |
| No. of Shares | 12.49Cr. |
| Book Value | ₹291.70 |
| Dividend Yield | 1.65% |
| ROCE | 33.15% |
| ROE | 24.26% |
| Face Value | ₹2 |
| Sales Growth | 16.41% |
| Profit Growth | 44.48% |
Ajanta Pharma Business Sector
Ajanta Pharma operates in several key business sectors, focusing on both branded and generic pharmaceutical formulations.
- Cardiology: Treating cardiovascular conditions like hypertension and heart disease.
- Ophthalmology: Eye care products, including treatments for conditions like glaucoma and conjunctivitis.
- Dermatology: Products for skin care, including treatment of acne, fungal infections, and other skin conditions.
- Pain Management: Analgesics and anti-inflammatory drugs.
- Gastroenterology: Treatments for digestive system disorders.
Ajanta Pharma’s diversified business sectors allow it to maintain a strong market presence across various regions and therapeutic categories, positioning the company for sustainable growth and market expansion.
Board Members
- Madhusudan Agrawal – Vice Chairman.
- Yogesh M. Agrawal – Managing Director.
- Rajesh M. Agrawal – Managing Director.
- Ranjit Singh – Managing Director.
- B. L. Kheruka – Independent Director.
- Anant H. Bhatt – Independent Director.
- Dinesh Mehta – Independent Director.
- Rama Kirloskar – Independent Director.
Ajanta Pharma Share Quarterly Results
| PARTICULARS | Mar 2024 | Jun 2024 |
|---|---|---|
| Net Sales | 926.07 | 1,077.27 |
| Total Expenditure | 698.92 | 761.44 |
| Operating Profit | 227.15 | 315.83 |
| Other Income | 33.68 | 28.37 |
| Interest | 1.42 | 0.72 |
| Depreciation | 33.47 | 32.92 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 225.94 | 310.56 |
| Tax | 63.25 | 74.53 |
| Profit After Tax | 162.69 | 236.03 |
| Adjusted EPS (Rs) | 12.88 | 18.83 |
Ajanta Pharma Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 3,411.27 | 3,971.12 |
| Total Expenditure | 2,711.99 | 2,851.69 |
| Operating Profit | 699.28 | 1,119.43 |
| Other Income | 132.75 | 116.48 |
| Interest | 5.23 | 6.80 |
| Depreciation | 126.95 | 132.16 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 699.85 | 1,096.95 |
| Tax | 141.13 | 289.71 |
| Net Profit | 558.72 | 807.24 |
| Adjusted EPS (Rs.) | 44.38 | 64.12 |
Ajanta Pharma Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹3402 | ₹3545 |
| 2026 | ₹3565 | ₹3735 |
| 2027 | ₹3765 | ₹3956 |
| 2028 | ₹3965 | ₹4145 |
| 2029 | ₹4159 | ₹4395 |
| 2030 | ₹4420 | ₹4705 |
| 2035 | ₹6125 | ₹7150 |
| 2040 | ₹9150 | ₹9950 |
Ajanta Pharma Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹3402 |
| February 2025 | ₹3425 |
| March 2025 | ₹3453 |
| April 2025 | ₹3443 |
| May 2025 | ₹3459 |
| June 2025 | ₹3481 |
| July 2025 | ₹3477 |
| August 2025 | ₹3488 |
| September 2025 | ₹3495 |
| October 2025 | ₹3502 |
| November 2025 | ₹3525 |
| December 2025 | ₹3545 |
Ajanta Pharma Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹3565 |
| February 2026 | ₹3577 |
| March 2026 | ₹3598 |
| April 2026 | ₹3625 |
| May 2026 | ₹3652 |
| June 2026 | ₹3641 |
| July 2026 | ₹3661 |
| August 2026 | ₹3678 |
| September 2026 | ₹3693 |
| October 2026 | ₹3702 |
| November 2026 | ₹3725 |
| December 2026 | ₹3735 |
Ajanta Pharma Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹3765 |
| February 2027 | ₹3783 |
| March 2027 | ₹3805 |
| April 2027 | ₹3825 |
| May 2027 | ₹3856 |
| June 2027 | ₹3838 |
| July 2027 | ₹3862 |
| August 2027 | ₹3883 |
| September 2027 | ₹3895 |
| October 2027 | ₹3905 |
| November 2027 | ₹3941 |
| December 2027 | ₹3956 |
Ajanta Pharma Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹3965 |
| February 2028 | ₹3979 |
| March 2028 | ₹3995 |
| April 2028 | ₹4012 |
| May 2028 | ₹4026 |
| June 2028 | ₹4049 |
| July 2028 | ₹4063 |
| August 2028 | ₹4058 |
| September 2028 | ₹4078 |
| October 2028 | ₹4089 |
| November 2028 | ₹4102 |
| December 2028 | ₹4145 |
Ajanta Pharma Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹4159 |
| February 2029 | ₹4171 |
| March 2029 | ₹4189 |
| April 2029 | ₹4195 |
| May 2029 | ₹4210 |
| June 2029 | ₹4256 |
| July 2029 | ₹4238 |
| August 2029 | ₹4265 |
| September 2029 | ₹4295 |
| October 2029 | ₹4321 |
| November 2029 | ₹4356 |
| December 2029 | ₹4395 |
Ajanta Pharma Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹4420 |
| February 2030 | ₹4459 |
| March 2030 | ₹4469 |
| April 2030 | ₹4495 |
| May 2030 | ₹4488 |
| June 2030 | ₹4510 |
| July 2030 | ₹4561 |
| August 2030 | ₹4591 |
| September 2030 | ₹4605 |
| October 2030 | ₹4625 |
| November 2030 | ₹4675 |
| December 2030 | ₹4705 |
Ajanta Pharma Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹6125 |
| April 2035 | ₹6340 |
| July 2035 | ₹6570 |
| October 2035 | ₹6890 |
| December 2035 | ₹7150 |
Ajanta Pharma Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹9150 |
| April 2040 | ₹9350 |
| July 2040 | ₹9610 |
| October 2040 | ₹9710 |
| December 2040 | ₹9950 |
Ajanta Pharma Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 66.27% |
| FIIs | 8.36% |
| DIIs | 17.42% |
| Others | 0% |
| Public | 7.94% |
Ajanta Pharma Company Competitors
- Piramal Pharma
- Natco Pharma
- Gland Pharma
- Lupin Ltd
- Abbott India
Bull Case of Ajanta Pharma (Reasons to Invest)
- Strong Export Growth: Ajanta Pharma has a significant presence in international markets, particularly in Asia and Africa. Continued growth in these regions can drive overall revenue.
- Innovative Product Portfolio: The company’s focus on developing innovative and differentiated products can lead to strong market positioning and customer loyalty.
- Strong R&D Capabilities: Ajanta Pharma’s investment in research and development can result in a steady pipeline of new and improved products, enhancing long-term growth prospects.
Bear Case of Ajanta Pharma (Risks Involved)
- Regulatory Risks: Compliance with international regulatory standards is crucial for Ajanta Pharma’s export markets. Any non-compliance issues can lead to bans or restrictions.
- Currency Fluctuations: As a significant portion of revenue comes from exports, adverse currency movements can impact profitability.
- Intense Competition: The pharmaceutical industry is highly competitive, with numerous players vying for market share, which can pressure prices and margins.
- Dependence on Key Markets: Over-reliance on certain geographic markets can expose the company to regional economic downturns or political instability.
Ajanta Pharma Share Price Target: FAQ
What will be the target of Ajanta Pharma Share for the year 2025?
By the end of the year 2025, its share price can reach ₹3545.
What will be the target of Ajanta Pharma Share for the year 2026?
By the end of the year 2026, its share price can reach ₹3735.
What will be the target of Ajanta Pharma Share for the year 2027?
By the end of the year 2027, its share price can reach ₹3956.
What will be the target of Ajanta Pharma Share for the year 2028?
By the end of the year 2028, its share price can reach ₹4145.
What will be the target of Ajanta Pharma Share for the year 2029?
By the end of the year 2029, its share price can reach ₹4395.
What will be the target of Ajanta Pharma Share for the year 2030?
By the end of the year 2030 its share price can reach ₹4705.
What is the Current market cap of Ajanta Pharma company?
At present the market cap of this company is ₹ 40,262.29 Cr.
What is the NSE symbol of Ajanta Pharma company?
The symbol of this company in NSE exchange is AJANTPHARM.
What is the BSE symbol of Ajanta Pharma company?
The symbol of this company in BSE exchange is 532331.
Read Also:
Piramal Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals
Pfizer Ltd (PFIZER) Share Price Target 2025 to 2040 Forecast & Fundamentals
Laurus Labs Share Price Target 2025 to 2040 Forecast & Fundamentals
